Ashleigh Hollowell

Adverse effects were found to be “uncommon” among a cohort of nearly 350 adults who participated in the first-ever U.S. state-regulated psilocybin study in Oregon.

Ten California addiction treatment providers are suing Cigna, which allegedly paid only 16.58% — $2.5 million — of $15.2 million in total that the providers had billed for 83 patients treated between March 2022 and March 2026.

Three of Michigan-based Quality Behavioral Health's addiction treatment facilities were raided by the FBI and local law

Psychiatric and addiction treatment providers in Montana are fighting to restore reimbursement for services they say have been

This is an exclusive BHB+ story. The prevalence of stimulant use disorders has surpassed the number of individuals with opioid use disorder for the first time, fueling new challenges for providers.

American adults and adolescents are increasingly turning to cannabis over alcohol as their preferred vice, which is creating new challenges for providers.

This is an exclusive BHB+ story. Venture capital investments in behavioral health are emerging from a lull as firms recalibrate their priorities in 2024 and identify new strategic targets now that the sector is maturing.

Nashville, Tennessee-based applied behavioral analysis (ABA) software platform Hi Rasmus received $50 million in new

Psychiatric medication prescribing practices have come under scrutiny since the Trump administration announced its plan to crack down on overprescribing and overmedicalization in the field.

Financial challenges at Aware Recovery Care have escalated, and new court filings suggest the Connecticut-based addiction